Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of a missed dose is very low.
Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Escitalopram (severe)
Ethinyl Estradiol (moderate)
Corticosteroids (severe)
Quinidine (severe)
Aspirin (moderate)
Antidiabetic medicines (moderate)
This medicine is used in the treatment of pneumonia which is a most common type of lung infection caused by Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, etc.
This medicine is used in the treatment of skin and skin structure infections such as cellulitis, wound infections, cutaneous abscess, etc. caused by bacteria such as Streptococcus pyogenes, Staphylococcus aureus, etc.
This medicine is used in the treatment of intra-abdominal infections caused by Escherichia coli, Proteus mirabilis, etc.
This medicine is used in the treatment of bronchitis which is an inflammation of the lining of the bronchial tubes caused by bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, H. parainfluenzae, etc.
This medicine is used in the treatment of Plague which is a serious bacterial illness caused by Yersinia pestis.
Abdominal pain (severe)
Blurred vision (severe)
Bone pain (severe)
Dark or clay colored stools (severe)
Dizziness (severe)
Irregular heartbeat (severe)
Headache (severe)
Severe sunburn (severe)
Acid or sour stomach (rare)
Nervousness (rare)
White patches in the mouth or on the tongue (rare)
This medicine is not recommended for use in patients with a known allergy to A-MOX 0.5% Eye Drops 3ml , any other quinolones, or any other inactive ingredients present along with it.
This medicine is not recommended for use in patients with a known history of tendon rupture or tendinitis (a condition in which the tissue connecting muscles to the bones becomes inflamed) due to the increased risk of worsening of the patient's condition.
This medicine is not recommended for use in patients with a known history or family history of myasthenia gravis (weakness and rapid fatigue of muscles under voluntary control) due to the increased risk of worsening of the patient's condition.
This medicine is not recommended for use in patients with severe liver impairment (Child-Pugh score: C) and in patients with transaminase levels greater than 5 times the upper limits of normal since the safety and efficacy of use are not clinically established.